跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 180 条关于
“Qinghui Linnuo”
全部
180
临床试验
98
药物
47
机构
14
资讯
21
上个月
T-MAXIMUM's Universal CAR-T MT027 to Debut Brain Metastasis Data at WCLC 2026 as Intracranial Tumors Emerge as Solid Tumor CAR-T's Second Battlefield
去年
Minghui Pharma's MHB018A Shows Promise in Thyroid Eye Disease Trial
去年
Minghui Pharmaceutical's MHB039A Shows Promise in Phase I Trial for Solid Tumors
去年
Minghui Pharma's MHB039A Shows Promise in Phase I Trial for Solid Tumors
去年
Minghui Pharmaceutical's MHB039A Shows Promise in Phase I Trial for Solid Tumors
去年
Minghui's MH004 Demonstrates Positive Phase III Results for Atopic Dermatitis
9个月前
Minghui Pharmaceutical Receives FDA Clearance for Phase III Trials of Novel Thyroid Eye Disease Treatment
去年
Minghui Pharmaceutical Secures $131 Million Pre-IPO Funding to Advance Oncology Pipeline and Commercial Launch
去年
Minghui and Qilu Pharmaceuticals Partner on B7-H3 ADC Development in $210 Million Deal for Greater China
去年
Minghui Pharmaceutical Initiates Phase II Trial Combining PD-1xVEGF Bispecific with TROP-2 ADC for Advanced NSCLC
第 1 页,共 3 页
上一页
下一页